Disulfiram and Cisplatin in Refractory TGCTs.
Condition(s):Germ Cell TumorLast Updated:October 4, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Germ Cell TumorLast Updated:October 4, 2023Completed
Condition(s):Hepatocellular Carcinoma; Gastrointestinal Cancer Metastatic; Neuroendocrine TumorsLast Updated:September 22, 2023Active, not recruiting
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, B-CellLast Updated:September 19, 2018Terminated
Condition(s):Chronic Graft Versus Host DiseaseLast Updated:December 26, 2018Terminated
Condition(s):Gastric CancerLast Updated:November 2, 2016Completed
Condition(s):Adult T-cell Leukemia-LymphomaLast Updated:September 19, 2018Completed
Condition(s):Small Cell Lung Cancer Extensive StageLast Updated:May 19, 2020Unknown status
Condition(s):Advanced Biliary Tract CancerLast Updated:March 21, 2024Recruiting
Condition(s):Classical Hodgkin LymphomaLast Updated:October 23, 2023Completed
Condition(s):Neuroendocrine TumorsLast Updated:June 22, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.